Shree Ganesh Remedies Submits Q4FY26 SEBI Compliance Certificate for Depositories Regulation

1 min read     Updated on 09 Apr 2026, 04:55 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Shree Ganesh Remedies Limited submitted its Q4FY26 compliance certificate under SEBI Regulation 74(5) to BSE on April 08, 2026. Registrar Bigshare Services confirmed the regulation is not applicable as all company shares remain in demat form with no rematerialisation requests during the quarter. The filing demonstrates complete digital shareholding compliance for the period ended March 31, 2026.

powered bylight_fuzz_icon
37236345

*this image is generated using AI for illustrative purposes only.

Shree Ganesh Remedies Limited has filed its quarterly compliance certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026. The submission was made to BSE Limited on April 08, 2026, fulfilling regulatory requirements for listed companies.

Regulatory Compliance Details

The certificate was issued under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, which pertains to the maintenance of securities in dematerialised form. Company Secretary Aditya Patel digitally signed and submitted the compliance document to the exchange.

Parameter: Details
Regulation: SEBI (Depositories and Participants) Regulations, 2018 - Section 74(5)
Quarter Ended: March 31, 2026
Submission Date: April 08, 2026
Registrar: Bigshare Services Private Limited
BSE Scrip Code: 540737

Registrar Confirmation

Bigshare Services Private Limited, serving as the company's Registrar and Share Transfer Agent, issued the compliance certificate dated April 03, 2026. The registrar confirmed that Regulation 74(5) is not applicable to Shree Ganesh Remedies Limited due to specific compliance conditions being met.

According to the certificate signed by Akash Shamal, Authorized Signatory at Bigshare Services, the entire shareholding of the company remains in dematerialised form. The registrar reported receiving no requests from shareholders for either rematerialisation or dematerialisation during the quarter ended March 31, 2026.

Digital Shareholding Status

The compliance certificate highlights the company's complete transition to digital shareholding. With all shares maintained in demat form and no conversion requests during Q4FY26, Shree Ganesh Remedies demonstrates full adherence to modern securities holding practices.

The company operates from its head office located at Plot No. 6011, 6012, 6002 & 6003, GIDC Estate, Ankleshwar, Gujarat, and maintains ISO certifications for quality, environmental, and occupational health standards. The regulatory filing reflects the company's commitment to maintaining transparent compliance with SEBI regulations governing depositories and participant operations.

Historical Stock Returns for Shree Ganesh Remedies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.73%+8.91%+9.30%+6.75%-27.05%+119.63%

How might Shree Ganesh Remedies' complete dematerialization status impact its liquidity and trading volumes in upcoming quarters?

What strategic initiatives could the company pursue given its strong regulatory compliance foundation and ISO certifications?

Will SEBI introduce additional regulatory requirements for depositories that could affect companies like Shree Ganesh Remedies in FY27?

like18
dislike

Shree Ganesh Remedies Submits EGM Voting Results to BSE with 99% Approval

2 min read     Updated on 07 Apr 2026, 03:34 AM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Shree Ganesh Remedies Limited successfully completed its Extra Ordinary General Meeting on April 06, 2026, and submitted comprehensive voting results to BSE Limited. The meeting addressed two key resolutions - re-appointment of Mr. Parth Chandulal Kothia as Whole-time Director and CFO, and approval of related party transaction for Mr. Gunjan Chandulal Kothia's remuneration. Both resolutions received overwhelming shareholder support with approval rates exceeding 99%, demonstrating strong confidence in the company's governance decisions.

powered bylight_fuzz_icon
37021748

*this image is generated using AI for illustrative purposes only.

Shree ganesh remedies Limited has submitted the voting results of its Extra Ordinary General Meeting held on April 06, 2026, to BSE Limited in compliance with Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting, conducted through video conferencing from 12:30 p.m. to 01:10 p.m., addressed critical resolutions regarding leadership appointments and related party transactions with overwhelming shareholder support.

Meeting Overview and Participation

The Extra Ordinary General Meeting was conducted entirely through Video Conferencing and Other Audio-Visual Means, ensuring compliance with circulars issued by the Ministry of Corporate Affairs and Securities and Exchange Board of India. The company reported strong participation from its shareholder base.

Meeting Details: Information
Total Shareholders on Record: 8,243
Promoter Group Attendance: 7
Public Shareholders Attendance: 35
Total Resolutions Passed: 2

Resolution Results and Voting Outcomes

Both resolutions presented at the meeting received substantial approval from shareholders, demonstrating strong confidence in the company's governance decisions.

Resolution 1: Director Re-appointment

The special resolution for re-appointment of Mr. Parth Chandulal Kothia (DIN: 08830608) as Whole-time Director and CFO achieved remarkable support:

Voting Category: Votes in Favour Votes Against Approval Rate
Public Non-institutions: 892,168 226 99.97%
Public Institutions: 0 149 0%
Overall Result: 892,168 375 99.96%

Resolution 2: Related Party Transaction

The ordinary resolution approving remuneration payment to Mr. Gunjan Chandulal Kothia also secured strong shareholder backing:

Voting Category: Votes in Favour Votes Against Approval Rate
Public Non-institutions: 891,918 476 99.95%
Public Institutions: 0 149 0%
Overall Result: 891,918 625 99.93%

E-Voting Process and Scrutiny

The company provided comprehensive e-voting facilities through Central Depository Services (India) Limited (CDSL), enabling both remote e-voting prior to the meeting and e-voting during the EGM. CS Vishal Thawani of VTSN and Associates LLP served as the appointed Scrutinizer, ensuring fair and transparent voting procedures.

The voting process included shareholders holding shares as of the cut-off date of March 30, 2026, with a total of 12,837,620 shares eligible for voting. The overall voting participation rate stood at 6.95% of outstanding shares.

Regulatory Compliance and Documentation

Aditya Patel, Company Secretary and Compliance Officer, submitted the comprehensive voting results to BSE Limited, fulfilling regulatory requirements under SEBI LODR Regulations. The detailed scrutinizer's report and voting results have been made available on the company's website, ensuring transparency for all stakeholders.

The successful completion of the EGM and subsequent regulatory submissions demonstrate the company's commitment to corporate governance standards and regulatory compliance.

Historical Stock Returns for Shree Ganesh Remedies

1 Day5 Days1 Month6 Months1 Year5 Years
-0.73%+8.91%+9.30%+6.75%-27.05%+119.63%

What strategic initiatives will Mr. Parth Chandulal Kothia implement as CFO to drive the company's financial performance in the coming quarters?

How might the approved related party transaction with Mr. Gunjan Chandulal Kothia impact the company's operational structure and future governance decisions?

Will Shree Ganesh Remedies consider expanding its leadership team or board composition following these appointments?

like15
dislike

More News on Shree Ganesh Remedies

1 Year Returns:-27.05%